PlainRecalls
FDA Drug Low Class III Terminated

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

Reported: October 3, 2018 Initiated: September 12, 2018 #D-1211-2018

Product Description

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

Reason for Recall

Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Details

Units Affected
5,424 bottles
Distribution
Indiana and Louisiana
Location
Hyderabad

Frequently Asked Questions

What product was recalled?
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90. Recalled by Hetero Labs, Ltd. - Unit III. Units affected: 5,424 bottles.
Why was this product recalled?
Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 3, 2018. Severity: Low. Recall number: D-1211-2018.